Clinical Trial Update: Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of prime/boost HIV vaccine regimens in healthy HIV-1 uninfected adults who are Ad5 seronegative. The update r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV vaccine prime/boost regimen

Snippet

Sponsor: HIV Vaccine Trials Network | Conditions: HIV Infections | Phase 1 | Status: COMPLETED